Early renal changes in hemizygous and heterozygous patients with Fabry's disease.

No abstract is available for this paper.

• Publication year

  1978

• Venue

  Kidney International

• Publication date

  1978-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/KI.1978.32PMID 418264
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Angiokeratoma corporis diffusum (universale) Fabry, as a sign of an unknown internal disease; two autopsy reports.

  2009cited by this paper
• Failure to correct the metabolic defect by renal allotransplantion in Fabry's disease.

  1976cited by this paper
• Angiokeratoma corporis diffusum (Fabry disease). A lysosomal disease.

  1976cited by this paper
• [Diagnosis of Fabry's disease].

  1976cited by this paper
• B.C.P. Jansen Institute, University of Amsterdam, Amsterdam, The Netherlands.

  1976cited by this paper
• [Renal transplantation in patients suffering from Fabry's disease. Kidney transplantation from an heterozygote subject to a subject without Fabry's disease].

  1975cited by this paper
• Striated membranous structures in renal glomerular tufts. An electron microscopy study of 340 human renal biopsies.

  1975cited by this paper
• Dense deposit disease: a variant of membranoproliferative glomerulonephritis.

  1975cited by this paper
• An example of rapid prenatal diagnosis of Fabry's disease usingmicrotechniques

  1974cited by this paper
• Renal pathologic lesions and functional alterations in a man with Fabry's disease.

  1973cited by this paper
• Renal transplantation in Fabry's disease.

  1973cited by this paper
• Kidney transplantation in Fabry's disease.

  1973cited by this paper
• Fabry's disease: enzymatic diagnosis of hemizygotes and heterozygotes. Alpha-galactosidase activities in plasma, serum, urine, and leukocytes.

  1973cited by this paper
• Reversal of an inborn sphingolipidosis (Fabry's disease) by kidney transplantation.

  1972cited by this paper
• AN AUTOPSY CASE OF FABRY'S DISEASE **

  1972cited by this paper
• Renal transplantation in Fabry's disease.

  1972cited by this paper
• Correction of enzymatic deficiencies by renal transplantation: fabry's disease.

  1972cited by this paper
• Correction of enzymatic deficiencies by renal transplantation: Fabry's disease.

  1972cited by this paper
• Enzyme replacement therapy by renal allotransplantation in Fabry's disease.

  1972cited by this paper
• Ceramide trihexosidosis (fabry's disease) without skin lesions.

  1971cited by this paper
• Pathologic lysosomes and increased urinary glycosylceramide excretion in Fabry's disease. Studies on a family with evidence of linkage with the sex-linked blood group Xg.

  1971cited by this paper
• Diagnosis of glycosphingolipidoses by urinary-sediment analysis.

  1971cited by this paper
• Angiokeratoma corporis diffusum (Fabry's disease) with renal, ocular and possibly cardiac involvement.

  1970cited by this paper
• Genetic inactivation of the alpha-galactosidase locus in carriers of Fabry's disease.

  1970cited by this paper
• Genetic Inactivation of the α-Galactosidase Locus in Carriers of Fabry's Disease

  1970cited by this paper
• Fabry's disease in children. An electron microscopic study.

  1969cited by this paper
• A Study of Fabry’s Disease

  1969cited by this paper
• Fabry’s disease in children

  1969cited by this paper
• A study of Fabry's disease. I. Clinical examination of a family with cornea verticillata.

  1969cited by this paper
• Fabry's disease (angiokeratoma corporis diffusum). A report of 5 cases with pain in the extremities as the chief symptom.

  1968cited by this paper
• Angiokeratoma corporis diffusum universale (Fabry's disease) in female subjects.

  1967cited by this paper
• Clinical and electron microscopic studies of a case of glycolipid lipoidosis (Fabry's disease)

  1967cited by this paper
• [Neurologic aspects of Fabry's angiokeratosis. Apropos of 2 cases].

  1967cited by this paper
• Angiokeratoma corporis diffusum--Fabry's disease.

  1967cited by this paper
• Fabry's disease (angiokeratoma corporis diffusum): case report on a rare disease.

  1965cited by this paper
• The Genetics of Angiokeratoma Corporis Diffusum (Fabry's Disease) and Its Linkage Relations with the Xg Locus.

  1965cited by this paper
• Angiokeratoma Corporis Diffusum (FABRY): Histochemical and Electron Microscopic Studies of the Skin*

  1965cited by this paper
• ANGIOKERATOMA CORPORIS DIFFUSUM UNIVERSALE: FABRY'S DISEASE; CASE REPORT AND REVIEW OF THE LITERATURE.

  1964cited by this paper
• Angiokeratoma corporis diffusum Fabry (Thesaurismosis hereditaria Ruiter-Pompen-Wyers)

  1964cited by this paper
• The renal lesion in angiokeratoma corporis diffusum (Fabry's disease).

  1963cited by this paper
• Angiokeratoma corporis diffusum. A clinical study of eight affected families.

  1962cited by this paper
• Angiokeratoma corporis diffusum--a case report.

  1961cited by this paper
• Angiokeratoma corporis diffusum universale (Fabry). Presenting as suspected myocardial infarction and pulmonary infarcts.

  1961cited by this paper
• Angiokeratoma Corporis Diffusum Universale (Fabry's Disease) in Two Brothers

  1961cited by this paper
• Gene Action in the X-chromosome of the Mouse (Mus musculus L.)

  1961cited by this paper
• Angiokeratoma corporis diffusum universale (hereditary dystopic lipidosis).

  1961cited by this paper
• The Renal Lesion in Angiokeratoma Corporis Diffusum

  1958cited by this paper
• ANGIOKERATOMA CORPORIS DIFFUSUM.

  1955cited by this paper
• Angiokeratoma corporis diffusum (universale) Fabry, as a sign of an unknown internal disease; two autopsy reports.

  1947cited by this paper

• Fabry nephropathy: a treatable cause of chronic kidney disease

  2024cites this paper
• Biomarkers in anderson-Fabry disease: what should we use in the clinical practice?

  2024cites this paper
• 2024 Update of the TSOC Expert Consensus of Fabry Disease.

  2024cites this paper
• Caseous Calcification of the Mitral Annulus

  2024cites this paper
• Impact of kidney biopsy on deciding when to initiate enzyme replacement therapy in children with Fabry disease

  2023cites this paper
• The evolution of the initial manifestations and renal involvement of chinese patients with classical and late-onset Fabry disease at different sexes and ages

  2023cites this paper
• Global reach of over 20 years of experience in the patient-centered Fabry Registry: Advancement of Fabry disease expertise and dissemination of real-world evidence to the Fabry community.

  2023cites this paper
• Urinary-derived extracellular vesicles reveal a distinct microRNA signature associated with the development and progression of Fabry nephropathy

  2023cites this paper
• Expert opinion on the recognition, diagnosis and management of children and adults with Fabry disease: a multidisciplinary Turkey perspective

  2022cites this paper
• The Impact of Kidney Biopsy for Fabry Nephropathy Evaluation on Patients’ Management and Long-Term Outcomes: Experience of a Single Center

  2022cites this paper
• Clinical relevance of globotriaosylceramide accumulation in Fabry disease and the effect of agalsidase beta in affected tissues.

  2022cites this paper
• A novel unbiased method reveals progressive podocyte globotriaosylceramide accumulation and loss with age in females with Fabry Disease.

  2022cites this paper
• A Case Study of Fabry Nephropathy and Its Progression: the First Reported Case in Malaysia

  2022cites this paper
• [Morphological characteristics of renal changes in Fabry disease].

  2022cites this paper
• Anderson-Fabry disease presenting with atrial fibrillation as earlier sign in a young patient: A case report

  2021cites this paper
• Role of microRNAs in Obesity-Related Kidney Disease

  2021cites this paper
• Textbook of Cardiorenal Medicine

  2021influential citation
• Pathology and pathogenic pathways in fabry nephropathy

  2021cites this paper
• A Case Study of Fabry Nephropathy and Its Progression: The First Reported Case in Malaysia

  2021cites this paper
• 2021 TSOC Expert Consensus on the Clinical Features, Diagnosis, and Clinical Management of Cardiac Manifestations of Fabry Disease.

  2021cites this paper
• Zebra bodies without Fabry disease or hydroxychloroquine

  2020cites this paper
• The Changing Landscape of Fabry Disease.

  2020cites this paper
• Type-5 Cardiorenal Syndrome

  2020cites this paper
• Effect of Renal Function Impairment on the Pharmacokinetics, Safety, and Tolerability of the Iminosugar Sinbaglustat

  2020cites this paper
• Fabry Disease on Peritoneal Dialysis with Cardiac Involvement

  2020cites this paper
• Fabry Disease

  2019cites this paper
• Retinal hyperreflective foci in Fabry disease

  2019cites this paper
• Cardiorenal Syndrome Type 5

  2019cites this paper
• A case of female Fabry disease revealed by renal biopsy

  2019cites this paper
• Early markers of heart and kidney damage in Fabry disease

  2018cites this paper
• An update on LDL apheresis for nephrotic syndrome

  2018cites this paper
• Age-related renal function decline in Fabry disease patients on enzyme replacement therapy: a longitudinal cohort study.

  2018cites this paper
• Fabry disease: characterisation of the plasma proteome pre- and post-enzyme replacement therapy

  2017cites this paper
• UvA-DARE ( Digital Academic Repository ) Glycosphingolipids and the central regulation of metabolism Sugar analogues as research tools

  2017cites this paper
• New biomarkers defining a novel early stage of Fabry nephropathy: A diagnostic test study.

  2017cites this paper
• Type-5 cardiorenal syndrome (CRS-5): an up to date

  2017cites this paper
• Pathomechanisms of renal Fabry disease

  2017influential citation
• Bedside Stereomicroscopy of Fabry Kidney Biopsies: An Easily Available Method for Diagnosis and Assessment of Sphingolipid Deposits

  2017cites this paper
• Fabry Disease Chronic Kidney Disease

  2016cites this paper
• One Year of Enzyme Replacement Therapy Reduces Globotriaosylceramide Inclusions in Podocytes in Male Adult Patients with Fabry Disease

  2016cites this paper
• Globotriaosylceramide (GL-3) Accumulation in the Renal Biopsy of a 1-year-old Patient with Fabry Disease and Ureteropelvic Junction Obstruction

  2016cites this paper
• reconocimiento en la edad pediátrica

  2016cites this paper
• The management and treatment of children with Fabry disease: A United States-based perspective.

  2016cites this paper
• Kidney transplantation from a mother with unrecognized Fabry disease to her son with low α‐galactosidase A activity: A 14‐year follow‐up without enzyme replacement therapy

  2016cites this paper
• X‐chromosome inactivation in female patients with Fabry disease

  2016cites this paper
• Reaccumulation of globotriaosylceramide in podocytes after agalsidase dose reduction in young Fabry patients

  2016cites this paper
• Clinical Manifestations of Anderson-Fabry ’ s Disease in Pediatrics

  2016cites this paper
• An open‐label study to determine the pharmacokinetics and safety of migalastat HCl in subjects with impaired renal function and healthy subjects with normal renal function

  2015cites this paper
• Characterization of Early Disease Status in Treatment-Naive Male Paediatric Patients with Fabry Disease Enrolled in a Randomized Clinical Trial

  2015cites this paper
• Substrate-specific gene expression profiles in different kidney cell types are associated with Fabry disease

  2015cites this paper
• Renal manifestations of metabolic disorders in children

  2015cites this paper
• Fabry’s disease: an example of cardiorenal syndrome type 5

  2015cites this paper
• Mosaicism of Podocyte Involvement Is Related to Podocyte Injury in Females with Fabry Disease

  2014cites this paper
• Fabry nephropathy: a review – how can we optimize the management of Fabry nephropathy?

  2014cites this paper
• Gaucher disease and Fabry disease: new markers and insights in pathophysiology for two distinct glycosphingolipidoses.

  2014cites this paper
• Cardiac manifestations in a two‑generation family with Fabry disease (RCD code: III‑2B.2a)

  2014cites this paper
• Risk of Death in Heart Disease is Associated With Elevated Urinary Globotriaosylceramide

  2014cites this paper
• The kidney in Fabry's disease

  2014cites this paper
• Fabry's disease.

  2014cites this paper
• Triglycerides in the Human Kidney Cortex: Relationship with Body Size

  2014cites this paper
• Lysosome dysfunction in the pathogenesis of kidney diseases

  2014cites this paper
• Hematuria in Children

  2013cites this paper
• Curvilinear bodies in hydroxychloroquine-induced renal phospholipidosis resembling Fabry disease

  2013cites this paper
• Genetic Abnormalities in Glomerular Function

  2013cites this paper
• Fibrosis: a key feature of Fabry disease with potential therapeutic implications

  2013cites this paper
• Agalsidase benefits renal histology in young patients with Fabry disease.

  2013cites this paper
• Fabry Disease (α-Galactosidase A Deficiency)

  2013cites this paper
• Renal complications of Fabry disease in children

  2013influential citation
• Fabry meets Markov: evaluating biochemistry, disease course and costs in support of health care policy

  2013cites this paper
• Estudio funcional de variantes en el gen GLA: implicación en la heterogeneidad clínica de la enfermedad de Fabry y en su tratamiento

  2013cites this paper
• [Guidelines for diagnosis, monitoring and treatment of Fabry disease].

  2013cites this paper
• Kidney transplantation and enzyme replacement therapy in patients with Fabry disease.

  2013cites this paper
• Early manifestations of Anderson Fabry disease

  2013cites this paper
• Markers of nephropathy in young Fabry disease patients; role of kidney biopsies and functional measurements

  2013cites this paper
• Podocyte Injury and GL-3 Accumulation are Progressive in Young Patients with Fabry Disease

  2013influential citation
• Anderson-Fabry disease in children.

  2013cites this paper
• Pulmonary involvement in Anderson Fabry Disease

  2013cites this paper
• Renal transplantation between siblings with unrecognized Fabry disease.

  2013cites this paper
• Fabry disease: pathogenesis and hispathology

  2012influential citation
• Clinical and pathological findings in women withFabry disease

  2012cites this paper
• Clinical and Pathological Findings in Women with Fabry Disease

  2012cites this paper
• Renal variant of Fabry disease with sporadic GLA gene mutation: role of early renal biopsy

  2012cites this paper
• Inherited glomerular diseases

  2012cites this paper
• Lysosomal delivery of therapeutic enzymes in cell models of Fabry disease

  2012cites this paper
• Agalsidase Bene fi ts Renal Histology in Young Patients with Fabry Disease

  2012cites this paper
• [Renal biopsies in Fabry disease: a multicenter French study].

  2012cites this paper
• A Case of Focal Segmental Glomerulosclerosis with Myeloid Bodies

  2012cites this paper
• Asimetrični dimetilarginin u bubrežnoj varijanti Fabryjeve bolesti

  2012influential citation
• Immunohistochemical diagnosis of Fabry nephropathy and localisation of globotriaosylceramide deposits in paraffin-embedded kidney tissue sections

  2012influential citation
• Unexpected Fabry Disease in a Renal Allograft Kidney: An Underrecognized Cause of Poor Allograft Function

  2011cites this paper
• Foot process effacement with normal urinalysis in classic fabry disease.

  2011cites this paper
• Progressive podocyte injury and globotriaosylceramide (GL-3) accumulation in young patients with Fabry disease.

  2011influential citation
• Receptor-Mediated Endocytosis of α-Galactosidase A in Human Podocytes in Fabry Disease

  2011cites this paper
• Renal Aspects and Enzyme Replacement Therapy of Fabry Disease

  2011cites this paper
• Renal outcomes of agalsidase beta treatment for Fabry disease: role of proteinuria and timing of treatment initiation

  2011cites this paper
• Kidney histologic alterations in α-Galactosidase-deficient mice

  2011cites this paper
• Secondary Glomerular Disease

  2011cites this paper
• Clinical Appearance and Management of Fabry Nephropathy in Greece

  2010cites this paper
• Prognostic indicators of renal disease progression in adults with Fabry disease: natural history data from the Fabry Registry.

  2010cites this paper
• Scoring system for renal pathology in Fabry disease: report of the International Study Group of Fabry Nephropathy (ISGFN).

  2010cites this paper